FDA approves tirzepatide, Eli Lillys new type 2 diabetes drug, and the company shares an estimated price Tirzepatide (Mounjaro), a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S
In the grand scheme of things, its a small trade-off for a serum that consistently makes my skin feel supported, balanced and resilient
Typical, evidence-backed benefits include: Hair Regrowth: +26% to +50% (5 months) Hair Density: +11.7% to +25.2% (36 Months) Reduced Shedding: -20% Anagen Phase: +7.5% Inflammatory Reduction: -30% Acccelerted Growth: +50% See below for quantified conclusions and full Clinical Studies
Research indicates that this endotoxemia-driven inflammation can cross the blood-brain barrier, activating microglial cells in the brain and driving the severe neuroinflammation, brain fog, and profound fatigue seen in both Long COVID and ME/CFS
Lifestyle changes such as quitting smoking, maintaining a moderate weight, reducing stress, and limiting alcohol consumption can help reduce the risk of ED